These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 10995787)

  • 1. Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.
    Kurihara T; Brough DE; Kovesdi I; Kufe DW
    J Clin Invest; 2000 Sep; 106(6):763-71. PubMed ID: 10995787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma model.
    Gupta VK; Park JO; Kurihara T; Koons A; Mauceri HJ; Jaskowiak NT; Kufe DW; Weichselbaum RR; Posner MC
    Gene Ther; 2003 Feb; 10(3):206-12. PubMed ID: 12571627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual E1A oncolytic adenovirus: targeting tumor heterogeneity with two independent cancer-specific promoter elements, DF3/MUC1 and hTERT.
    Doloff JC; Jounaidi Y; Waxman DJ
    Cancer Gene Ther; 2011 Mar; 18(3):153-66. PubMed ID: 20865021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter.
    Chen L; Chen D; Manome Y; Dong Y; Fine HA; Kufe DW
    J Clin Invest; 1995 Dec; 96(6):2775-82. PubMed ID: 8675647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity of an oncolytic herpes simplex virus for cells expressing the DF3/MUC1 antigen.
    Kasuya H; Pawlik TM; Mullen JT; Donahue JM; Nakamura H; Chandrasekhar S; Kawasaki H; Choi E; Tanabe KK
    Cancer Res; 2004 Apr; 64(7):2561-7. PubMed ID: 15059912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H; Zhang L; Tang Y; Deisseroth A
    Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus vector-based purging of multiple myeloma cells.
    Teoh G; Chen L; Urashima M; Tai YT; Celi LA; Chen D; Chauhan D; Ogata A; Finberg RW; Webb IJ; Kufe DW; Anderson KC
    Blood; 1998 Dec; 92(12):4591-601. PubMed ID: 9845525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma.
    Liu Y; Ye T; Sun D; Maynard J; Deisseroth A
    Hum Gene Ther; 2004 Jul; 15(7):637-47. PubMed ID: 15242524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene.
    Tai YT; Strobel T; Kufe D; Cannistra SA
    Cancer Res; 1999 May; 59(9):2121-6. PubMed ID: 10232598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
    Zhang J; Wei F; Wang H; Li H; Qiu W; Ren P; Chen X; Huang Q
    Cancer Biother Radiopharm; 2010 Aug; 25(4):487-95. PubMed ID: 20735209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
    Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
    J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral vectors with E1A regulated by tumor-specific promoters are selectively cytolytic for breast cancer and melanoma.
    Zhang L; Akbulut H; Tang Y; Peng X; Pizzorno G; Sapi E; Manegold S; Deisseroth A
    Mol Ther; 2002 Sep; 6(3):386-93. PubMed ID: 12231175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.
    Dwyer RM; Bergert ER; O'connor MK; Gendler SJ; Morris JC
    Clin Cancer Res; 2005 Feb; 11(4):1483-9. PubMed ID: 15746050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolysis and suppression of tumor growth by a GFP-expressing oncolytic adenovirus controlled by an hTERT and CMV hybrid promoter.
    Davis JJ; Wang L; Dong F; Zhang L; Guo W; Teraishi F; Xu K; Ji L; Fang B
    Cancer Gene Ther; 2006 Jul; 13(7):720-3. PubMed ID: 16485010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice.
    Sarkar D; Su ZZ; Vozhilla N; Park ES; Gupta P; Fisher PB
    Proc Natl Acad Sci U S A; 2005 Sep; 102(39):14034-9. PubMed ID: 16172403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H; Wei F; Li H; Ji X; Li S; Chen X
    Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer.
    Wirth T; Zender L; Schulte B; Mundt B; Plentz R; Rudolph KL; Manns M; Kubicka S; Kühnel F
    Cancer Res; 2003 Jun; 63(12):3181-8. PubMed ID: 12810646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplified Muc1-specific gene expression in colon cancer cells utilizing a binary system in adenoviral vectors.
    Block A; Milasinovic D; Mueller J; Schaefer P; Schaefer H; Greten H
    Anticancer Res; 2002; 22(6A):3285-92. PubMed ID: 12530077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus.
    Lim HY; Ahn M; Chung HC; Gardner TA; Kao C; Lee SJ; Kim SJ
    Cancer Gene Ther; 2004 Aug; 11(8):532-8. PubMed ID: 15167900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir.
    Manome Y; Abe M; Hagen MF; Fine HA; Kufe DW
    Cancer Res; 1994 Oct; 54(20):5408-13. PubMed ID: 7923173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.